Drug application
NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)
Drugs@FDA ANDA 209182 · AM REGENT
Key facts
| Drug name | NEOSTIGMINE METHYLSULFATE |
|---|---|
| Active ingredients | NEOSTIGMINE METHYLSULFATE |
| Application type | ANDA |
| Application number | 209182 |
| Company | AM REGENT |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 5MG/10ML (0.5MG/ML) |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | May 4, 2018 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.